Core Viewpoint - Novartis plans to invest $23 billion in U.S. infrastructure over the next five years, including the expansion of operations and the establishment of a manufacturing hub in North Carolina [1] Company Summary - The investment will significantly enhance Novartis's manufacturing capabilities in the U.S. market [1] - This move is part of a broader strategy to strengthen the company's presence and operational efficiency in North America [1] Industry Summary - The pharmaceutical industry is witnessing increased investments in domestic manufacturing, reflecting a trend towards localized production [1] - Such investments are likely to contribute to job creation and economic growth in the regions where these facilities are established [1]
Novartis to build manufacturing hub in North Carolina, creating 700 jobs